Knight Initiative News

Wu Tsai Neuro affiliate Lauren O’Connell explores the fundamental questions that underlie human relationships

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.

Young adults crave closeness, says Stanford psychologist Jamil Zaki, but often misjudge how much their peers want that, too. His research found strategies that can help nudge people to take a chance on one another.

This week on the podcast, Stanford radiology faculty Kim Butts Pauly and Raag Airan help us dive deep into the brain with focused ultrasound

In the lab of Lauren O’Connell, associate professor of biology, researchers look to amphibian species to learn how animals evolve in response to changing environments.

Our brains and digestive tracts are in constant communication. When that communication goes off the rails, research suggests diseases and disorders can result.

Stanford researchers have created a compound that relieves multiple types of pain in mice without building tolerance or causing psychoactive side effects.

The 1970s papers from Goldberg and Wurtz made ambitious mechanistic studies of higher brain functions seem feasible.

Mice learn fastest and most reliably when they experience an increase in dopamine paired with an inhibition of serotonin in their nucleus accumbens, a new study shows, helping to resolve long-standing questions about the neuromodulators’ relationship.

A new generation of researchers at Stanford’s Wu Tsai Neurosciences Institute is developing tools to modify brain activity for research and clinical applications—without drilling through the skull.

Stanford Medicine research demonstrates a new way of detecting cells implicated in the malfunctions that cause psychiatric diseases.

Academic leaders debated the future of the intersecting study of natural and artificial intelligence at Wu Tsai Neuro’s Annual Symposium

This week on the podcast, Stanford neurobiologist Robert Sapolsky lays out his view that we should stop judging one another (and ourselves) for behaviors we can't control

New research from the Malenka lab reveals that reward-based learning requires the two neuromodulators to balance one another's influence.

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

Science Corporation's retinal implant, built on the research of faculty affiliate Daniel Palanker, has allowed some people who lost their central vision to read, play cards, and recognize faces.

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.